Anne Quinn Young, MPH, is the Chief Mission Officer at the MMRF and works closely with the senior leadership team on setting the strategic vision for the organization to advance its mission of accelerating a cure for every patient. She is also responsible for building and stewarding high-level relationships with partners, supporters, and stakeholders, who are critical to the organization’s success. Previously, Anne served as Brand President and Chief Marketing and Development Officer, where she oversaw all marketing, communications, and educational programming and built the organization’s first Development team.
Anne has been named to the PharmaVoice 100, and represents the MMRF on a number of working groups and committees including the Harvard Business School (HBS) Kraft Precision Medicine Accelerator and the Cancer Support Community Frankly Speaking About Cancer: Multiple Myeloma National Advisory Board. She has co-authored a number of peer-reviewed abstracts and publications on the MMRF Precision Medicine Model and identifying knowledge gaps and opportunities to improve patient empowerment and engagement in optimizing their disease journey, has been a featured speaker at a number of industry conferences, and has been interviewed by a mix of trade and consumer media.
Anne joined the MMRF in 2002 and has worked closely with the MMRF founder and other senior leaders to develop and launch pioneering models and build novel collaborations that have helped to transform outcomes for multiple myeloma patients. Prior to joining the MMRF, she was a consultant in the Healthcare Practice of Datamonitor, a global market research and business intelligence company. She previously worked in healthcare public relations at Burson-Marsteller and the Chandler Chicco Agency, following a postgraduate internship at the Department of Justice, Antitrust Division. Anne has a Masters of Public Health from the Mailman School of Public Health of Columbia University and graduated cum laude from Dartmouth College with a Bachelor of Arts in Government.